State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$3.42B |
| 2 |
Cigna
CI
|
+$1.25B |
| 3 |
CVS Health
CVS
|
+$1.25B |
| 4 |
Marathon Petroleum
MPC
|
+$805M |
| 5 |
Diamondback Energy
FANG
|
+$589M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$3.86B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.31B |
| 3 |
PX
Praxair Inc
PX
|
+$2.1B |
| 4 |
Apple
AAPL
|
+$1.38B |
| 5 |
ANDV
Andeavor
ANDV
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.79% |
| 2 | Technology | 15.42% |
| 3 | Healthcare | 14.78% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNTR
3376
DELISTED
Venator Materials PLC
VNTR
| $405K | ﹤0.01% |
96,641
-3,131
| -3% | -$20.2K |
|
|
PHIIK
3377
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $405K | ﹤0.01% |
219,157
-30,409
| -12% | -$176K |
|
3378
Hawthorn Bancshares
HWBK
$274M
| $403K | ﹤0.01% |
23,185
+8,133
| +54% | +$153K |
|
|
AMPE
3379
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $402K | ﹤0.01% |
3,395
-201
| -6% | -$30.8K |
|
|
SBBP
3380
DELISTED
Strongbridge Biopharma plc.
SBBP
| $399K | ﹤0.01% |
89,163
+4,454
| +5% | +$21.7K |
|
3381
Turkcell
TKC
$4.88B
| $396K | ﹤0.01% |
70,507
-3,286
| -4% | -$17.5K |
|
3382
electroCore
ECOR
$56.2M
| $386K | ﹤0.01% |
4,110
+2,662
| +184% | +$348K |
|
|
BT
3383
DELISTED
BT Group plc (ADR)
BT
| $385K | ﹤0.01% |
+25,246
| New | +$402K |
|
3384
Five Point Holdings
FPH
$379M
| $384K | ﹤0.01% |
55,301
+369
| +0.7% | +$2.91K |
|
3385
MeiraGTx Holdings
MGTX
$1.14B
| $380K | ﹤0.01% |
+39,440
| New | +$498K |
|
3386
Veritone
VERI
$112M
| $377K | ﹤0.01% |
99,100
-32,036
| -24% | -$212K |
|
|
CAJ
3387
DELISTED
Canon, Inc.
CAJ
| $374K | ﹤0.01% |
13,563
| – | – |
|
|
XNET
3388
Xunlei
XNET
$341M
| $367K | ﹤0.01% |
107,853
+2,136
| +2% | +$11.5K |
|
|
TARO
3389
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $366K | ﹤0.01% |
4,324
-100
| -2% | -$9.64K |
|
|
AINC
3390
DELISTED
Ashford Inc.
AINC
| $365K | ﹤0.01% |
7,042
+391
| +6% | +$24.6K |
|
|
MLNT
3391
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $365K | ﹤0.01% |
92,051
+21,354
| +30% | +$273K |
|
|
CMCM
3392
Cheetah Mobile
CMCM
$95M
| $364K | ﹤0.01% |
11,905
-10,235
| -46% | -$405K |
|
3393
Bank7 Corp
BSVN
$486M
| $355K | ﹤0.01% |
+26,590
| New | +$463K |
|
|
WBK
3394
DELISTED
Westpac Banking Corporation
WBK
| $355K | ﹤0.01% |
20,320
| – | – |
|
3395
Orion
OEC
$376M
| $353K | ﹤0.01% |
13,958
+516
| +4% | +$13.5K |
|
3396
Teck Resources
TECK
$31.8B
| $346K | ﹤0.01% |
16,068
+368
| +2% | +$7.98K |
|
3397
ORIX
IX
$44B
| $345K | ﹤0.01% |
24,135
-155
| -0.6% | -$2.43K |
|
3398
Manulife Financial
MFC
$74.4B
| $344K | ﹤0.01% |
24,225
-1,768
| -7% | -$28K |
|
|
BBL
3399
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $339K | ﹤0.01% |
+8,086
| New | +$332K |
|
3400
Galectin Therapeutics
GALT
$196M
| $335K | ﹤0.01% |
97,558
+54,180
| +125% | +$259K |
|
Similar funds
State Street's Q4 2018 Portfolio in Review
As of Q4 2018, State Street held 3,872 positions worth $1.1T, down 16% from $1.3T the previous quarter. Its ten largest holdings account for 17% of the portfolio.
State Street's Q4 2018 filing shows 102 new, 1,442 increased, 2,108 reduced and 110 closed positions. Its largest new stake was Linde: 21,625,224 shares worth $3.37B. The largest sale was Aetna Inc, an estimated $3.86B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- State Street's largest Q4 2018 buy was Linde: 21,625,224 shares worth $3.37B.
- State Street added most to Cigna in Q4 2018, an estimated $1.25B increase.
- State Street's biggest Q4 2018 reduction was Apple, cutting an estimated $1.38B.
- State Street fully exited Aetna Inc in Q4 2018, selling an estimated $3.86B.
- State Street's ten largest holdings make up 17% of its $1.1T portfolio in Q4 2018.
- State Street opened 102 new positions and closed 110 in Q4 2018.
- State Street's portfolio value fell 16% quarter-over-quarter to $1.1T.
Based on State Street's 13F filing for Q4 2018, filed 12 Feb 2019.